TSX News -
Finning to Release Q4 and Annual 2019 Results and Hold Investor Call on February 12, 2020
VANCOUVER, British Columbia, Jan. 29, 2020 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) will release Q4 and annual 2019 […]
Voleo Appoints Glen Wilson, Voleo Director as Interim CEO
VANCOUVER, British Columbia, Jan. 29, 2020 (GLOBE NEWSWIRE) — Voleo Trading Systems Inc. (TRAD: TSX-V, VLEOF: OTC-QB) (“Voleo”, the “Company”), […]
Trex Company Widens Its Midwest Footprint
Amerhart Brings #1 Decking and Railing Brand into Eastern Kansas and Western MissouriWINCHESTER, Va., Jan. 29, 2020 (GLOBE NEWSWIRE) — […]
Verizon “Built on 5G Challenge” Winner, Ario, Gets $1M to develop 5G concept
What you need to know:Ario wins $1 million to bring its augmented reality enterprise productivity platform to life on Verizon […]
Rogers partners with Fleet Complete to bring Canadian businesses critical next-generation fleet management technology
Offerings will improve fleet driver and vehicle safety through next-gen telematics solutionsPowered by its national LTE-M network, Rogers is enabling […]
Rogers s’associe à Fleet Complete pour offrir aux entreprises canadiennes de la technologie essentielle pour la gestion de parcs de véhicules de nouvelle génération
Les offres permettront d’améliorer la sécurité des véhicules des parcs et des conducteurs grâce à des solutions télématiques de nouvelle […]
January 29, 2020: Zanzibar Starts Exploration on Tanzanian Gold Properties and announces stock option grant
VANCOUVER, British Columbia, Jan. 29, 2020 (GLOBE NEWSWIRE) — Zanzibar Gold Inc. (the “Company”) (ZBR – CSE; ZNZBF – OTC […]
Progressive Reports December 2019 Results
MAYFIELD VILLAGE, OHIO, Jan. 29, 2020 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for December […]
OptimizeRx Seals Multi-Million Dollar Enterprise Deal for Integrated Platform
ROCHESTER, Mich., Jan. 29, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for […]
Spring Bank Discontinues Development of Inarigivir for the Treatment of HBV
Continuing to focus on immuno-oncology & inflammation, including IV STING agonist clinical program, oral STING antagonist platform and STING agonist […]
